1. Home
  2. IPHA vs BFIN Comparison

IPHA vs BFIN Comparison

Compare IPHA & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • BFIN
  • Stock Information
  • Founded
  • IPHA 1999
  • BFIN 1924
  • Country
  • IPHA France
  • BFIN United States
  • Employees
  • IPHA N/A
  • BFIN N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • BFIN Savings Institutions
  • Sector
  • IPHA Health Care
  • BFIN Finance
  • Exchange
  • IPHA Nasdaq
  • BFIN Nasdaq
  • Market Cap
  • IPHA 150.9M
  • BFIN 168.0M
  • IPO Year
  • IPHA 2019
  • BFIN N/A
  • Fundamental
  • Price
  • IPHA $1.95
  • BFIN $12.93
  • Analyst Decision
  • IPHA Strong Buy
  • BFIN
  • Analyst Count
  • IPHA 1
  • BFIN 0
  • Target Price
  • IPHA $11.50
  • BFIN N/A
  • AVG Volume (30 Days)
  • IPHA 50.9K
  • BFIN 20.0K
  • Earning Date
  • IPHA 03-20-2025
  • BFIN 02-11-2025
  • Dividend Yield
  • IPHA N/A
  • BFIN 3.11%
  • EPS Growth
  • IPHA N/A
  • BFIN N/A
  • EPS
  • IPHA N/A
  • BFIN 0.33
  • Revenue
  • IPHA $36,202,722.00
  • BFIN $49,205,000.00
  • Revenue This Year
  • IPHA N/A
  • BFIN N/A
  • Revenue Next Year
  • IPHA $101.65
  • BFIN $0.91
  • P/E Ratio
  • IPHA N/A
  • BFIN $39.09
  • Revenue Growth
  • IPHA N/A
  • BFIN N/A
  • 52 Week Low
  • IPHA $1.29
  • BFIN $9.60
  • 52 Week High
  • IPHA $3.51
  • BFIN $13.97
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 56.50
  • BFIN 53.88
  • Support Level
  • IPHA $1.72
  • BFIN $12.29
  • Resistance Level
  • IPHA $1.92
  • BFIN $13.56
  • Average True Range (ATR)
  • IPHA 0.11
  • BFIN 0.38
  • MACD
  • IPHA 0.02
  • BFIN 0.09
  • Stochastic Oscillator
  • IPHA 89.74
  • BFIN 59.87

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About BFIN BankFinancial Corporation

BankFinancial Corp is a national bank principally engaged in the business of commercial, family and personal banking. It offers customers a broad range of loan, deposit, trust and other financial products and services. The Bank offers customers a broad range of loan, deposit, trust and other financial products and services through all full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through Internet Branch.

Share on Social Networks: